Antibe Therapeutics Inc (ATE.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Sales | 2,631 | 2,337 | 2,100 | 0 | 0 |
| Cost of Goods | 1,472 | 1,318 | 1,063 | N/A | N/A |
| Gross Profit | 1,159 | 1,019 | 1,037 | N/A | N/A |
| Operating Expenses | 2,085 | 2,580 | 1,515 | 757 | 380 |
| Operating Income | -926 | -1,561 | -478 | -757 | -380 |
| Interest Expense | 197 | 190 | 135 | N/A | N/A |
| Other Income | -29 | 138 | -137 | 2 | 1 |
| Pre-tax Income | -1,152 | -1,613 | -749 | -755 | -379 |
| Income Tax | -45 | -862 | -3 | N/A | N/A |
| Net Income Continuous | -1,107 | -751 | -746 | -755 | -379 |
| Net Income | $-1,107 | $-751 | $-746 | $-755 | $-379 |
| EPS Basic Total Ops | -0.10 | -0.20 | -0.10 | -0.20 | -0.10 |
| EPS Basic Continuous Ops | -0.10 | -0.20 | -0.10 | -0.20 | -0.10 |
| EPS Diluted Total Ops | -0.10 | -0.20 | -0.10 | -0.20 | -0.10 |
| EPS Diluted Continuous Ops | -0.10 | -0.20 | -0.10 | -0.20 | -0.10 |
| EBITDA(a) | $-870 | $-1,270 | $-607 | $-757 | $-380 |